|
|
AlzGuard.org Web Links and References
- ^ Brookmeyer R, Gray S, Kawas C (September 1998). "Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset". Am J Public Health 88 (9): 1337–42. PMID 9736873.
- ^ a b 2006 prevalence estimate:
Brookmeyer R, Johnson E, Ziegler-Graham K, MH Arrighi (July 2007). "Forecasting the global burden of Alzheimer’s disease". Alzheimer's and Dementia 3 (3): 186–91. doi:10.1016/j.jalz.2007.04.381. http://works.bepress.com/cgi/viewcontent.cgi?article=1022&context=rbrookmeyer. Retrieved on 2008-06-18.
(PDF)World population prospects: the 2006 revision, highlights. Working Paper No. ESA/P/WP.202. Population Division, Department of Economic and Social Affairs, United Nations. 2007. http://un.org/esa/population/publications/wpp2006/WPP2006_Highlights_rev.pdf. Retrieved on 2008-08-27.
- ^ "What is Alzheimer’s disease?". Alzheimers.org.uk. August 2007. http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=100. Retrieved on 2008-02-21.
- ^ a b c d e f g Waldemar G, Dubois B, Emre M, et al (January 2007). "Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline". Eur. J. Neurol. 14 (1): e1–26. doi:10.1111/j.1468-1331.2006.01605.x. PMID 17222085.
- ^ "Alzheimer's diagnosis of AD". Alzheimer's Research Trust. http://www.alzheimers-research.org.uk/info/diagnosis/. Retrieved on 2008-02-29.
- ^ Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, Marder K, Albers MW, Stern Y, Devanand DP (2005). "A 10-item smell identification scale related to risk for Alzheimer's disease". Ann. Neurol. 58 (1): 155–160. doi:10.1002/ana.20533. PMID 15984022.
- ^ "Understanding stages and symptoms of Alzheimer's disease". National Institute on Aging. 2007-10-26. http://www.nia.nih.gov/Alzheimers/Publications/stages.htm. Retrieved on 2008-02-21.
- ^ a b c d e Mölsä PK, Marttila RJ, Rinne UK (August 1986). "Survival and cause of death in Alzheimer's disease and multi-infarct dementia". Acta Neurol. Scand. 74 (2): 103–7. PMID 3776457.
- ^ a b c Mölsä PK, Marttila RJ, Rinne UK (March 1995). "Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia". Acta Neurol. Scand. 91 (3): 159–64. PMID 7793228.
- ^ a b c Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (June 2004). "The importance of neuritic plaques and tangles to the development and evolution of AD". Neurology 62 (11): 1984–9. PMID 15184601.
- ^ "Alzheimer's Disease Clinical Trials". US National Institutes of Health. http://www.clinicaltrials.gov/ct2/results?term=alzheimer. Retrieved on 2008-08-18.
- ^ "Can Alzheimer's disease be prevented" (pdf). National Institute on Aging. 2006-08-29. http://www.nia.nih.gov/NR/rdonlyres/63B5A29C-F943-4DB7-91B4-0296772973F3/0/CanADbePrevented.pdf. Retrieved on 2008-02-29.
- ^ a b "The MetLife study of Alzheimer’s disease: The caregiving experience" (PDF). MetLife Mature Market Institute. August 2006. http://www.metlife.com/WPSAssets/14050063731156260663V1FAlzheimerCaregivingExperience.pdf. Retrieved on 2008-02-12.
- ^ a b c Thompson CA, Spilsbury K, Hall J, Birks Y, Barnes C, Adamson J (2007). "Systematic review of information and support interventions for caregivers of people with dementia". BMC Geriatr 7: 18. doi:10.1186/1471-2318-7-18. PMID 17662119.
- ^ a b Schneider J, Murray J, Banerjee S, Mann A (August 1999). "EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I—Factors associated with carer burden". International Journal of Geriatric Psychiatry 14 (8): 651–661. doi:10.1002/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B. PMID 10489656.
- ^ a b Murray J, Schneider J, Banerjee S, Mann A (August 1999). "EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: II--A qualitative analysis of the experience of caregiving". International Journal of Geriatric Psychiatry 14 (8): 662–667. doi:10.1002/(SICI)1099-1166(199908)14:8<662::AID-GPS993>3.0.CO;2-4. PMID 10489657.
- ^ a b c d Bonin-Guillaume S, Zekry D, Giacobini E, Gold G, Michel JP (January 2005). "Impact économique de la démence (English: The economical impact of dementia)" (in French). Presse Med 34 (1): 35–41. ISSN 0755-4982. PMID 15685097.
- ^ a b c d e Meek PD, McKeithan K, Schumock GT (1998). "Economic considerations in Alzheimer's disease". Pharmacotherapy 18 (2 Pt 2): 68–73; discussion 79–82. PMID 9543467.
- ^ Preclinical:
Linn RT, Wolf PA, Bachman DL, et al (May 1995). "The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort". Arch. Neurol. 52 (5): 485–90. PMID 7733843.
Saxton J, Lopez OL, Ratcliff G, et al (December 2004). "Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset". Neurology 63 (12): 2341–7. PMID 15623697.
Twamley EW, Ropacki SA, Bondi MW (September 2006). "Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease". J Int Neuropsychol Soc 12 (5): 707–35. doi:10.1017/S1355617706060863. PMID 16961952.
- ^ Perneczky R, Pohl C, Sorg C, Hartmann J, Komossa K, Alexopoulos P, Wagenpfeil S, Kurz A (2006). "Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues". Age Ageing 35 (3): 240–245. doi:10.1093/ageing/afj054. PMID 16513677.
- ^ Arnáiz E, Almkvist O (2003). "Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease". Acta Neurol. Scand., Suppl. 179: 34–41. doi:10.1034/j.1600-0404.107.s179.7.x. PMID 12603249.
|
|
|
